Found 102 matching trials
Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases
PHASE1The CATARSIS study explores the use of anti-CD19 CAR T-cell therapy as a no...
Location
Fondazione Policlinico Universitario A. Gemelli IRCCS
CAR-T Therapy Targeting CD19 and BCMA in Highly Sensitized Kidney Transplant Participants
EARLY_PHASE1The purpose of this study is to assess the safety, tolerability, and effica...
Location
Tongji Hospital, Tongji Medical Collage of Huazhong University of Science & Technology
A Pediatric Trial of Genetically Modified Autologous T Cells Directed Against CD19 for Relapsed CD19+ Acute Lymphoblastic Leukemia
PHASE1Patients with relapsed leukemia often develop resistance to chemotherapy. F...
Status
Active Not Recruiting
Location
Seattle Children's Hospital
Study of ALA-101 in Patients With CD19 Positive Non-Hodgkin Lymphoma and Leukemia.
PHASE1Phase 1 Open-Label Dose-Escalation and Expansion Study to Assess the Safety...
Location
St. Vincent's Hospital
Bispecific Antibody-Based Salvage Therapy Followed by CAR-T ยฑ ASCT in R/R Aggressive B-Cell Lymphoma
PHASE2This study consists of two sequential treatment phases. In the first phase,...
Location
Institute of Hematology & Blood Diseases Hospital
Allogeneic CART-19 for Elderly Relapsed/Refractory CD19+ ALL
PHASE1The purpose of this study is to evaluate the safety and efficiency of allog...
Location
Affiliated Hospital of Academy of Military Medical Sciences ,
A Study of C-CAR039 in Subjects With Relapsed and/or Refractory B Cell Non-Hodgkin's Lymphoma
PHASE1This is a single-center, open-label study to evaluate the safety and effica...
Location
Peking University Cancer Hospital
CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus
PHASE1This is a single-center, single-arm, open-label phase 1/2 study of CART19 i...
Location
Children's Hospital of Philadelphia
A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies
PHASE1This is an open-label, multicenter, Phase 1/2 study evaluating the safety a...
Location
University of Kansas
UCD19 CAR T Therapy in Adults With B-ALL and MRD Positivity in CR1
PHASE1This open-label, single arm Phase 1/1b trial aims to determine the safety a...
Location
University of Colorado Hospital